Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

详细信息    查看全文

• 作者：Peter Alping ; Thomas Frisell ; Lenka Novakova ; Protik Islam-Jakobsson ; Jonatan Salzer ; Anna Bjö ; rck ; Markus Axelsson ; Clas Malmeströ ; m ; Katharina Fink ; Jan Lycke ; Anders Svenningsson and Fredrik Piehl
• 刊名：Annals of Neurology
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：79
• 期：6
• 页码：950-958
• 全文大小：288K
• ISSN：1531-8249

文摘

Many JC virus antibody-positive relapsing–remitting multiple sclerosis (RRMS) patients who are stable on natalizumab switch to other therapies to avoid progressive multifocal leukoencephalopathy.